Human CD19+ B cells from cord blood

HCMSCB19C-1EA 0 EUR
HCMSCB19C-1
Human CD19+ B cells from cord blood
CD19+ B cells are isolated from mononuclear cells by positive selection using immunomagnetic cell separation procedures. Human cord blood is collected aseptically at the time of delivery from healthy pregnant women under institutional review board (IRB) approved procedures.

  • Purity >90% by flow cytometry
  • Test negative for HIV, HTLVI/II, HCV, HBV, WNV, syphilis, CMV, NAT, NAT WNV and Chagas
  • Cryopreserved in CryoStor® CS10 media

CD19+ B cells play an essential role in the adaptive immune response. CD19+ B Cells are responsible for the recognition and clearance of antigens in the system and, in the process, creating cells with the purpose of immunosurveillance. The wide range and sensitivity of the B cell to antigens lies in the process in which its receptor, the B cell receptor, develops.

Storage: Either prepare cells for long term storage in liquid nitrogen vapour phase or thaw for use. Storage in liquid phase nitrogen is NOT recommended. Short term storage of cells (less than 2 weeks) at –80°C is acceptable, but should be minimised to ensure maximum stability. Once thawed, samples must be used immediately.

Caution: Intended for research use only and not for direct therapeutic or diagnostic use in human or animals, or for further manufacturing of therapeutic products or devices.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR